Scripta Insights, a digital health company focused on pharmacy navigation, is teaming up with Mark Cuban Cost Plus Drug Company to bring transparent drug pricing to patients.
Scripta will integrate Cost Plus Drugs’ discounted pricing into its platform Med Mapper, which the company said maps every drug on the market to every possible way users can save money on their medications.
For instance, through its member app and portal, Scripta provides members with personalized savings reports that the company claims can show members all their medication options, ranging from alternative prescriptions available through their health plan or a cash pay option like Cost Plus Drugs.
“Mark Cuban is a serial entrepreneur who shares our mission to shake up the pharmacy benefit market, putting the power of choice in the patient’s hands, under the care of their doctors, for the first time,” Eric Levin, CEO of Scripta Insights, said in a press release. “Cost Plus Drugs has been making noise with its unprecedented deep discounts, transparent pricing and vertically-integrated supply chain, and we couldn’t be more excited to team up with them to help our clients’ members get ‘The Right Meds at The Best Price.’”
Scripta, founded in 2019, works with self-insured employers, health plans and their members. A team of doctors, pharmacists and data analysts helped build its proprietary AI platform, Med Mapper.
The company aims to provide human resource and pharmacy teams with easy-to-use tools to help members understand their medication options, adhere to provider instructions and improve outcomes. The tools help lower out-of-pocket costs and plan spend.
“We are excited to work with Scripta Insights to bring lower prescription drug prices to consumers,” Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company, said in the announcement. “Cost Plus Drugs and Scripta Insights share a common goal of providing consumers the lowest possible price for their prescription medications. With Cost Plus Drugs, consumers can be confident they are getting a fair price and the convenience of medication mailed directly to their homes.”
Earlier this year, Cost Plus Drugs tapped RevSpring, maker of healthcare payment solutions, for its payment technology as part of a new program with U.S. pharmacies. The program is designed to make drugs more affordable and to relieve financial stress on participating pharmacies by delivering them more revenue.
More recently, Cost Plus Drugs entered the male fertility space in partnership with Posterity Health. The partners’ goal is to make it easier for men to access medications that treat infertility, low testosterone and sexual dysfunction at an affordable price.